AMO Development, LLC

Clinical trials sponsored by AMO Development, LLC, explained in plain language.

Now part of Johnson & Johnson JNJ NYSE

A subsidiary of Johnson & Johnson focused on ophthalmic surgical products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Completed 1

Laser eye surgery may offer a One-Time fix for reading glasses — a trial puts it to the test

Symptom relief Completed

This trial tests whether wavefront-guided LASIK, set to create monovision in one eye for near vision and the other for distance, can improve vision and reduce the need for reading glasses in people with presbyopia. About 219 participants aged 40 and older with mild to moderate ne…

Sponsor: AMO Development, LLC • Aim: Symptom relief

Last updated Jul 25, 2026 00:00 UTC

AMO Development, LLC

Laser eye surgery may offer a One-Time fix for reading glasses — a trial puts it to the test